earnings
confidence high
sentiment positive
materiality 0.75
Illumina Q2 EPS $1.19 non-GAAP, revenue $1.06B; raises FY2025 guidance
ILLUMINA, INC.
2025-Q2 EPS reported
$2.31
revenue$2,100,000,000
- Revenue $1.059B down 3% YoY; GAAP EPS $1.49, non-GAAP EPS $1.19 vs. $1.09 prior year.
- FY2025 guidance raised: revenue decline (2.5%)-(0.5%), non-GAAP op margin 22%-22.5%, EPS $4.45-$4.55.
- Repurchased 4.5M shares for $380M at avg $84.66; ~$800M remaining authorization.
- Signed definitive agreement to acquire SomaLogic from Standard BioTools; close expected H1 2026.
- Q2 free cash flow $204M; cash and short-term investments $1.16B.